Skip to content Provide accessibility feedback
For Providers
For Patients
Customer Stories
About Us
Contact Us
Magnifying glass Search

Volpara has entered into a Scheme Implementation Agreement with Lunit, Inc.

The Optimal Resources for Breast Care (2024 Standards) specify that an NAPBC accredited site must consider genetic testing for all newly diagnosed patients and patients at high risk for genetic cancer.

Add NCCN elligibility in same EHR workflow

Volpara Risk Pathways® allows you to add genetic testing eligibility without changing your workflow:

  • Use same patient questionnaire to collect data for NCCN eligibility
  • Autopopulate letters, mammography reports and referrer summaries with NCCN eligibility to inform testing necessity
  • Make NCCN eligibility visible on the patient record and in registries, worklists and dashboards in the EHR
Genetics magnifying glass

Streamline genetic test ordering and counseling

From pre-filed genetic test order forms and options to connect to genetic counseling – your breast center can use Volpara Risk Pathways tools to better co-ordinate patient care.

Partners include:

  • Ambry
  • Myriad
  • Natera
  • Invitae
Lab connect

Providers rely on Volpara

Want genetic lab freedom of choice?

Schedule an appointment to discuss your genetic counseling and testing workflows.